Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 842 Shares

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 842 shares of the business’s stock in a transaction dated Friday, March 28th. The stock was sold at an average price of $50.00, for a total transaction of $42,100.00. Following the completion of the sale, the director now owns 278,945 shares in the company, valued at approximately $13,947,250. This trade represents a 0.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Pro-Dex Price Performance

Shares of NASDAQ:PDEX opened at $51.40 on Wednesday. The company has a market capitalization of $167.62 million, a PE ratio of 25.57 and a beta of 0.68. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. The stock has a fifty day moving average of $40.45 and a 200-day moving average of $40.43. Pro-Dex, Inc. has a one year low of $16.84 and a one year high of $59.60.

Pro-Dex (NASDAQ:PDEX) last announced its earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 EPS for the quarter, beating the consensus estimate of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. As a group, equities analysts anticipate that Pro-Dex, Inc. will post 2 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. EAM Investors LLC acquired a new stake in shares of Pro-Dex during the fourth quarter valued at approximately $1,047,000. O Shaughnessy Asset Management LLC acquired a new stake in Pro-Dex during the 4th quarter valued at $995,000. 683 Capital Management LLC purchased a new stake in shares of Pro-Dex in the fourth quarter valued at $739,000. Ritholtz Wealth Management acquired a new stake in shares of Pro-Dex in the fourth quarter worth $572,000. Finally, American Century Companies Inc. purchased a new position in shares of Pro-Dex during the fourth quarter valued at $558,000. 15.28% of the stock is currently owned by institutional investors and hedge funds.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.